AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
4h
AZoLifeSciences on MSNThe Antibiotic Arms Race: Can Science Stay Ahead of Rapidly Evolving Antibiotic-Resistant Bacteria?A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...
4h
New Scientist on MSNEngineered bacteria could break down unrecyclable nylon in clothesClothes and fishing nets that are made of nylon often end up in landfill or dumped in oceans, but a new way to break down the ...
In this one, the researchers discovered that coffee drinking correlated with an increase in several bacterial species, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results